AI in Medicine and Healthcare: Hype, Promise, Reality and Pitfalls

Program Description

Artificial Intelligence (AI) is disrupting and transforming many industries globally. When developed carefully, AI holds similarly enormous promise to impact medicine and healthcare delivery radically.

Fun fact: Healthcare AI start-ups raised more than $12B in 2021 funding.

Proven, emerging, and nascent examples of AI abound - some of these include advancing drug discovery & R&D acceleration; rapidity of accurate diagnosis through image recognition & processing; personalized treatment options through responsive algorithms & assisted surgery; efficacious healthcare delivery including pandemic preparedness, and more.

The science, practice, and business considerations of AI in Medicine and Healthcare will be kicked off with our Keynote speaker, Dr. Michael Segal, Founder of SimulConsult. His main work has been in what is now called “Augmented Intelligence,” developing the SimulConsult clinical diagnosis software based on how experienced clinicians think about a diagnosis. He will be followed by a moderated panel discussion on the current applications of AI in med-tech.

Program Moderator

Shanthi Ramakrishnan, CEO & President, eDevices

Shanthi has a record of delivering breakthrough products, innovative business models, and value-added services in the Medical Device, Digital Health, and Technology sectors. She has served in large MedTech, small and start-up companies globally.

Keynote

Michael Segal M.D., Ph.D., Founder & Chief Scientist, SimulConsult

Dr. Segal has a long history of interest in artificial intelligence and neural networks and patterned the SimulConsult software after how experienced clinicians think about a diagnosis.

Program Panelists

Jayender Jagadeesan, Ph.D., Associate Professor, Harvard Medical School

Dr. Jagadeesan is a Lead Investigator at the Brigham and Women's Hospital and an Associate Member of the Broad Institute. His research interests include image-guided therapy, surgical navigation, robotics, and machine learning.

Peter Traianou, Global Vice President, Clinical Research, Medical Science, Medtronic

Peter Traianou is currently the Global Vice President, CRMS for Medtronic’s Surgical Robotics Operating Unit, where he is responsible for formulating clinical strategy, organic and inorganic portfolio development, educational and training programs, and third-party strategic alliances.

Jeff Zampieron, Software Architect, MedAcuity Software

Jeffrey Zampieron is an experienced hands-on technical leader with deep domain expertise in the areas of cloud services, distributed systems, cyber security, AI/ML, computer vision, and surgical robotics within the medical, commercial, and defense markets.

Join this timely keynote presentation, and blue-ribbon panel discussion focused on Artificial Intelligences (AI) positive influence on patients, caregivers, and providers. Ask questions and contribute your insights during the interactive audience segment.

Who should attend?

C-level executives, board members, investors, and other senior leaders who want a better understanding of how Artificial Intelligence (AI) is reshaping healthcare.

Speaker Bios

Jayender Jagadeesan, Ph.D., Associate Professor, Harvard Medical School

Dr. Jagadeesan is an Associate Professor at Harvard Medical School, Lead Investigator at the Brigham and Women's Hospital, and an Associate Member of the Broad Institute. Before his current appointment, he completed his Ph.D. from the University of Western Ontario, Canada, and his Bachelors of Technology (B.Tech.) from the Indian Institute of Technology, Kanpur, India. His research interests include image-guided therapy, surgical navigation, robotics, and machine learning.

Shanthi Ramakrishnan, CEO & President, eDevice

Shanthi Ramakrishnan’s foray in the medical device sector began more than 15yrs ago at Medtronic’s Cardiac Rhythm division, specifically to spur Remote Patient Management – a remote care delivery model. She has led sales, strategic marketing, R&D, and commercial teams to develop and launch more than 50 Class III and Class II implantable devices, blood diagnostics, and transfusion platforms. At eDevice, she transformed a tech company into a digital health firm that specializes in enabling connected care with a comprehensive suite of products and services.

Michael Segal M.D., Ph.D., Founder & Chief Scientist, SimulConsult

Dr. Segal has worked across many of the key areas related to artificial intelligence in medicine. He is a pediatric neurologist and also a neuroscientist who developed the microisland culture method. This model allows scientists to study networks as small as one or two neurons, work that won national and international young investigator awards, and set the stage for later work on the molecular mechanism of attention deficit disorder. He has a longstanding interest in computer neural networks, having taught on the subject as a faculty member at Harvard as far back as the 1980s and writing one of the early reviews of where the field was headed (PMID: 17747494). His main work has been in what is now called “Augmented Intelligence”, developing the SimulConsult clinical diagnosis software, based on how experienced clinicians actually think about diagnosis. Dr. Segal did his undergraduate work at Harvard and his MD and PhD at Columbia, where his thesis project outlined rules for the types of chemical synapses that will form in a nervous system. He is on the Electronic Communication Committee of the Child Neurology Society, is one of the medical advisers of the Periodic Paralysis Association, and has been on the Scientific Program Committee of the American Medical Informatics Association. Click here for a list of publications.

Peter Traianou, Global Vice President, Clinical Research, Medical Science, Medtronic Global Vice President, Clinical Research and Medical Science, Medtronic Surgical Robotics President and Founder – Emerging Health Connections, LLC Board Member, Messages of Hope Foundation Board Member, VitalTrace, Pty. Ltd.

Peter Traianou is currently the Global Vice President, CRMS for Medtronic’s Surgical Robotics Operating Unit, where he is responsible for the formulation of clinical strategy, organic and inorganic portfolio development, educational and training programs and third-party strategic alliances. He is also the President and Founder of Emerging Health Connections, LLC, a strategic advisory firm specializing in accelerating the commercialization of new businesses and new technologies in the healthcare/med tech sector. He brings over twenty-five years of operating experience within the industry. Mr. Traianou has held leadership positions in a variety of roles including President, Chief of Staff, Global Vice President, Regional Vice President and board advisor, and has a demonstrated track record of dynamic change management and building highly effective global teams.

Prior to founding Emerging Health Connections, LLC, Mr. Traianou held roles of varying responsibilities with Covidien, Agnovos Healthcare and Intuitive Surgical in locations such as Perth, Australia, New Haven, Connecticut, Singapore and Boston, Massachusetts, Rockville, Maryland and Sunnyvale, California.

Mr. Traianou is currently an advisor to the Board of Directors at the Messages of Hope Foundation, a non-profit out of Boston, MA and VitalTrace, Australia a start up developing a novel diagnostic tool for childbirth application. He holds a Bachelor’s Degree in Science (Physics) and a postgraduate diploma in Education from Edith Cowan Universit

Jeff Zampieron, Software Architect, MedAcuity Software

Jeffrey Zampieron is an experienced hands-on technical leader with deep domain expertise in the areas of cloud services, distributed systems, cyber security, computer vision, and surgical robotics within the medical, commercial and defense markets. Presently, Jeffrey is using his expertise to champion a variety of medical software projects with MedAcuity Software.

Prior to MedAcuity, at Beco as CTO, Mr. Zampieron led a broad range of projects supporting their novel IoT based hyper-location platform. In 2018, Beco was acquired by Convene (https://www.convene.com) and Jeff joined Convene as Director of Cloud Services supporting a distributed global development organization.

Jeff contributes to a few different open source projects and has given a number of interviews and talks in his areas of interest. He is an author of several patents and conference papers. Mr. Zampieron received his BS/MS from RIT in Computer Engineering.

SPONSORSHIP KINDLY PROVIDED BY